Effects of fertility drugs on cancers other than breast and gynecologic malignancies

Fertility and Sterility

Volumn 104, Issue 4, 2015, Pages 980-988

  Brinton, Louise A ^a   Moghissi, Kamran S ^b   Scoccia, Bert ^c   Lamb, Emmet J ^d   Trabert, Britton ^a   Niwa, Shelley ^e   Ruggieri, David ^f   Westhoff, Carolyn L ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d STANFORD UNIVERSITY   (United States)

^e WESTAT   (United States)

^f IM Systems Inc   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cancer; clomiphene citrate; gonadotropins; infertility; risk

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; FERTILITY PROMOTING AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; DRUG EXPOSURE; FEMALE; FEMALE GENITAL TRACT CANCER; FEMALE INFERTILITY; FERTILITY; FOLLOW UP; HUMAN; INFERTILITY THERAPY; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; NEOPLASM; NULLIGRAVIDA; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; THYROID CANCER; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; GENITAL NEOPLASMS, FEMALE; INFERTILITY, FEMALE; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDY; THYROID NEOPLASMS;

ADULT; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; FERTILITY AGENTS, FEMALE; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, FEMALE; HUMANS; INFERTILITY, FEMALE; LUNG NEOPLASMS; MELANOMA; MIDDLE AGED; NEOPLASMS; PREGNANCY; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 84942833538     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.06.045     Document Type: Article

References (51)

1. L.A. Brinton, V.V. Sahasrabuddhe, and B. Scoccia Fertility drugs and the risk of breast and gynecologic cancers Semin Reprod Med 30 2012 131 145
2. L.A. Brinton, G.L. Gierach, A. Andaya, Y. Park, A. Schatzkin, A.R. Hollenbeck, and et al. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort Cancer Epidemiol Biomarkers Prev 20 2011 900 911
3. K.K. Tsilidis, N.E. Allen, T.J. Key, K. Bakken, E. Lund, F. Berrino, and et al. Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition Br J Cancer 103 2010 1755 1759
4. R. Zamora-Ros, S. Rinaldi, C. Biessy, A. Tjønneland, J. Halkjaer, A. Fournier, and et al. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study Int J Cancer 136 2015 1218 1227
5. J. Kaae, A. Andersen, H.A. Boyd, J. Wohlfahrt, and M. Melbye Reproductive history and cutaneous malignant melanoma: a comparison between women and men Am J Epidemiol 165 2007 1265 1270
6. P.N. Fuller Malignant melanoma of the ovary and exposure to clomiphene citrate: a case report and review of the literature Am J Obstet Gynecol 180 1999 1499 1503
7. E. Kuppens, W. Bergman, K. Welvaart, J.A. Bruijn, and E. Scheffer Multiple primary melanomas in a patient with familial-type DNS during clomiphene-induced pregnancy Melanoma Res 2 1992 71 74
8. M.D. Althuis, B. Scoccia, E.J. Lamb, K.S. Moghissi, C.L. Westhoff, J.E. Mabie, and et al. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs Am J Obstet Gynecol 193 2005 668 674
9. R. Calderon-Margalit, Y. Friedlander, R. Yanetz, K. Kleinhaus, M.C. Perrin, O. Manor, and et al. Cancer risk after exposure to treatments for ovulation induction Am J Epidemiol 169 2009 365 375
10. C.G. Hannibal, A. Jensen, H. Sharif, and S.K. Kjaer Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study Cancer Causes Control 19 2008 759 765
11. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore, and S.G. Self Risk of cutaneous melanoma in a cohort of infertile women Melanoma Res 5 1995 123 127
12. L.M. Stewart, C.D. Holman, J.C. Finn, D.B. Preen, and R. Hart Association between in-vitro fertilization, birth and melanoma Melanoma Res 23 2013 489 495
13. C.G. Hannibal, A. Jensen, H. Sharif, and S.K. Kjaer Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study Hum Reprod 23 2008 451 456
14. L.N. Kolonel, J.H. Hankin, L.R. Wilkens, F.H. Fukunaga, and M.W. Hinds An epidemiologic study of thyroid cancer in Hawaii Cancer Causes Control 1 1990 223 234
15. C. La Vecchia, E. Ron, S. Franceschi, L. Dal Maso, S.D. Mark, L. Chatenoud, and et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones Cancer Causes Control 10 1999 157 166
16. I. dos Santos Silva, P.A. Wark, V.A. McCormack, D. Mayer, C. Overton, V. Little, and et al. Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort Br J Cancer 100 2009 1824 1831
17. A. Venn, L. Watson, J. Lumley, G. Giles, C. King, and D. Healy Breast and ovarian cancer incidence after infertility and in vitro fertilisation Lancet 346 1995 995 1000
18. A.N. Yli-Kuha, M. Gissler, R. Klemetti, R. Luoto, and E. Hemminki Cancer morbidity in a cohort of 9175 Finnish women treated for infertility Hum Reprod 27 2012 1149 1155
19. L.A. Brinton, B. Scoccia, K.S. Moghissi, C.L. Westhoff, S. Niwa, D. Ruggieri, and et al. Long-term relationship of ovulation-stimulating drugs to breast cancer risk Cancer Epidemiol Biomarkers Prev 23 2014 584 593
20. L.A. Brinton, C.L. Westhoff, B. Scoccia, E.J. Lamb, B. Trabert, S. Niwa, and et al. Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort Hum Reprod 28 2013 2813 2821
21. B. Trabert, E.J. Lamb, B. Scoccia, K.S. Moghissi, C.L. Westhoff, S. Niwa, and et al. Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort Fertil Steril 100 2013 1660 1666
22. L.A. Brinton, E.J. Lamb, K.S. Moghissi, B. Scoccia, M.D. Althuis, J.E. Mabie, and et al. Ovarian cancer risk associated with varying causes of infertility Fertil Steril 82 2004 405 414
23. L.A. Brinton, K.S. Moghissi, C.L. Westhoff, E.J. Lamb, and B. Scoccia Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome) Fertil Steril 94 2010 1787 1792
24. M.B. Jhaveri, M.S. Driscoll, and J.M. Grant-Kels Melanoma in pregnancy Clin Obstet Gynecol 54 2011 537 545
25. S. Gandini, S. Iodice, E. Koomen, P.A. Di, F. Sera, and S. Caini Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis Eur J Cancer 47 2011 2607 2617
26. M. Kvaskoff, A. Bijon, S. Mesrine, M.C. Boutron-Ruault, and F. Clavel-Chapelon Cutaneous melanoma and endogenous hormonal factors: a large French prospective study Am J Epidemiol 173 2011 1192 1202
27. C.S. Lea, E.A. Holly, P. Hartge, J.S. Lee, D.I.V. Guerry, D.E. Elder, and et al. Reproductive risk factors for cutaneous melanoma in women: a case-control study Am J Epidemiol 165 2007 505 513
28. M. Lens, and V. Bataille Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues Cancer Causes Control 19 2008 437 442
29. L. Naldi, A. Altieri, G.L. Imberti, L. Giordano, S. Gallus, and V.C. La Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy Ann Epidemiol 15 2005 545 550
30. C. Ohata, T. Tadokoro, and S. Itami Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas J Dermatol 35 2008 215 221
31. F. Tomao, A. Papa, G. Lo Russo, S. Zuber, G.P. Spinelli, L. Rossi, and et al. Correlation between fertility drugs use and malignant melanoma incidence: the state of the art Tumour Biol 35 2014 8415 8424
32. D. Feskanich, D.J. Hunter, W.C. Willett, D. Spiegelman, M.J. Stampfer, F.E. Speizer, and et al. Oral contraceptive use and risk of melanoma in premenopausal women Br J Cancer 81 1999 918 923
33. E.R. Koomen, A. Joosse, R.M. Herings, M.K. Casparie, H.J. Guchelaar, and T. Nijsten Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study Ann Oncol 20 2009 358 364
34. J.Y. Tang, K.M. Spaunhurst, R.T. Chlebowski, J. Wactawski-Wende, E. Keiser, F. Thomas, and et al. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials J Natl Cancer Inst 103 2011 1469 1475
35. E. Linos, S.M. Swetter, M.G. Cockburn, G.A. Colditz, and C.A. Clarke Increasing burden of melanoma in the United States J Invest Dermatol 129 2009 1666 1674
36. M.R. Karagas, M.S. Zens, T.A. Stukel, A.J. Swerdlow, S. Rosso, A. Osterlind, and et al. Pregnancy history and incidence of melanoma in women: a pooled analysis Cancer Causes Control 17 2006 11 19
37. B. Modan, E. Ron, L. Lerner-Geva, T. Blumstein, J. Menczer, J. Rabinovici, and et al. Cancer incidence in a cohort of infertile women Am J Epidemiol 147 1998 1038 1042
38. M. Spaan, A.W. van den Belt-Dusebout, M. Schaapveld, T.M. Mooij, C.W. Burger, and F.E. van Leeuwen Melanoma risk after ovarian stimulation for in vitro fertilization Hum Reprod 30 2015 1216 1228
39. P. Young, D. Purdie, L. Jackman, D. Molloy, and A. Green A study of infertility treatment and melanoma Melanoma Res 11 2001 535 541
40. K. Vuong, K. McGeechan, B.K. Armstrong, and A.E. Cust Risk prediction models for incident primary cutaneous melanoma: a systematic review JAMA Dermatol 150 2014 434 444
41. G. Mintziori, D.G. Goulis, K.A. Toulis, C.A. Venetis, E.M. Kolibianakis, and B.C. Tarlatzis Thyroid function during ovarian stimulation: a systematic review Fertil Steril 96 2011 780 785
42. E. Ron, R.A. Kleinerman, J.D. Boice Jr., V.A. LiVolsi, J.T. Flannery, and J.F. Fraumeni Jr. A population-based case-control study of thyroid cancer J Natl Cancer Inst 79 1987 1 12
43. A. Zervoudakis, H.D. Strickler, Y. Park, X. Xue, A. Hollenbeck, A. Schatzkin, and et al. Reproductive history and risk of colorectal cancer in postmenopausal women J Natl Cancer Inst 103 2011 826 834
44. G.C. Kabat, A.B. Miller, and T.E. Rohan Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women Int J Cancer 122 2008 643 646
45. J. Lin, S.M. Zhang, N.R. Cook, J.E. Manson, J.E. Buring, and I.M. Lee Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study Am J Epidemiol 165 2007 794 801
46. P.T. Campbell, P. Newcomb, S. Gallinger, M. Cotterchio, and J.R. McLaughlin Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer Cancer Causes Control 18 2007 723 733
47. M.D. Long, C.F. Martin, J.A. Galanko, and R.S. Sandler Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study Am J Gastroenterol 105 2010 1843 1850
48. P.A. Newcomb, Y. Zheng, V.M. Chia, L.M. Morimoto, V.P. Doria-Rose, A. Templeton, and et al. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women Cancer Res 67 2007 7534 7539
49. G.C. Kabat, A.B. Miller, and T.E. Rohan Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study Int J Cancer 120 2007 2214 2220
50. C.L. Meinhold, A. Berrington de González, E.D. Bowman, A.V. Brenner, R.T. Jones, J.V. Lacey Jr., and et al. Reproductive and hormonal factors and the risk of nonsmall cell lung cancer Int J Cancer 128 2011 1404 1413
51. A.C. Pesatori, M. Carugno, D. Consonni, N.E. Caporaso, S. Wacholder, M. Tucker, and et al. Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study Int J Cancer 132 2013 2630 2639